Explore the future of generic drug markets (2026-2030). Analysis of patent cliffs, the rise of biosimilars, and economic shifts in India and China.
Read More
Biologic drugs can't be copied like regular pills because they're made from living cells, not chemicals. That's why biosimilars exist - not generics. Here's how they work and why they're so hard to make.
Read More
Biosimilars are not generics - tiny biological differences can trigger immune responses in some patients. Learn why immunogenicity matters, how it's measured, and what real-world data shows about differences between biosimilars and their reference biologics.
Read More